These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome? Cremesti AE; Goni FM; Kolesnick R FEBS Lett; 2002 Oct; 531(1):47-53. PubMed ID: 12401201 [TBL] [Abstract][Full Text] [Related]
27. Sphingolipid partitioning into ordered domains in cholesterol-free and cholesterol-containing lipid bilayers. Wang TY; Silvius JR Biophys J; 2003 Jan; 84(1):367-78. PubMed ID: 12524290 [TBL] [Abstract][Full Text] [Related]
28. Changes in membrane biophysical properties induced by sphingomyelinase depend on the sphingolipid N-acyl chain. Pinto SN; Laviad EL; Stiban J; Kelly SL; Merrill AH; Prieto M; Futerman AH; Silva LC J Lipid Res; 2014 Jan; 55(1):53-61. PubMed ID: 24163422 [TBL] [Abstract][Full Text] [Related]
29. The role of the 'sphingoid motif' in shaping the molecular interactions of sphingolipids in biomembranes. Dingjan T; Futerman AH Biochim Biophys Acta Biomembr; 2021 Nov; 1863(11):183701. PubMed ID: 34302797 [TBL] [Abstract][Full Text] [Related]
30. Sphingoid bases of dietary ceramide 2-aminoethylphosphonate, a marine sphingolipid, absorb into lymph in rats. Tomonaga N; Tsuduki T; Manabe Y; Sugawara T J Lipid Res; 2019 Feb; 60(2):333-340. PubMed ID: 30552287 [TBL] [Abstract][Full Text] [Related]
31. Correlation between bioeffector characteristics of sphingolipids and the structure of their hydrophobic fragment. Dyatlovitskaya EV Biochemistry (Mosc); 1998 Jan; 63(1):55-61. PubMed ID: 9526095 [TBL] [Abstract][Full Text] [Related]
32. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy? Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782 [TBL] [Abstract][Full Text] [Related]
33. Phytosphingosine, sphingosine and dihydrosphingosine ceramides in model skin lipid membranes: permeability and biophysics. Školová B; Kováčik A; Tesař O; Opálka L; Vávrová K Biochim Biophys Acta Biomembr; 2017 May; 1859(5):824-834. PubMed ID: 28109750 [TBL] [Abstract][Full Text] [Related]
34. Effect of Phosphatidylcholine Unsaturation on the Lateral Segregation of Palmitoyl Ceramide and Palmitoyl Dihydroceramide in Bilayer Membranes. Al Sazzad MA; Slotte JP Langmuir; 2016 Jun; 32(23):5973-80. PubMed ID: 27218704 [TBL] [Abstract][Full Text] [Related]
35. Myristate-derived d16:0 sphingolipids constitute a cardiac sphingolipid pool with distinct synthetic routes and functional properties. Russo SB; Tidhar R; Futerman AH; Cowart LA J Biol Chem; 2013 May; 288(19):13397-409. PubMed ID: 23530041 [TBL] [Abstract][Full Text] [Related]
36. Tackling the biophysical properties of sphingolipids to decipher their biological roles. Carreira AC; Ventura AE; Varela AR; Silva LC Biol Chem; 2015 Jun; 396(6-7):597-609. PubMed ID: 25581755 [TBL] [Abstract][Full Text] [Related]
37. Fenofibrate lowers atypical sphingolipids in plasma of dyslipidemic patients: A novel approach for treating diabetic neuropathy? Othman A; Benghozi R; Alecu I; Wei Y; Niesor E; von Eckardstein A; Hornemann T J Clin Lipidol; 2015; 9(4):568-75. PubMed ID: 26228675 [TBL] [Abstract][Full Text] [Related]
38. Influence of intracellular membrane pH on sphingolipid organization and membrane biophysical properties. Varela AR; Gonçalves da Silva AM; Fedorov A; Futerman AH; Prieto M; Silva LC Langmuir; 2014 Apr; 30(14):4094-104. PubMed ID: 24654655 [TBL] [Abstract][Full Text] [Related]